Tocris Bioscience™ Varenicline tartrate

Description

Selective α4β2 partial agonist; orally active

Orally active, subtype-selective partial agonist at α4β2 nicotinic receptors (Ki values are 0.06, 240, 322 and 3540 nM for α4β2, α3β4, α7, α1βγδ receptors respectively). Reduces nicotine-evoked dopamine release in vitro and decreases nicotine self-administration in vivo. Also potently activates PSAM4-5-HT3 and PSAM4-GlyR chimeric ion channels (EC50 values are 4 and 1.6 nM, respectively)

This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.

Specifications

Chemical Identifiers

• CAS: 375815-87-5
• Molecular Formula: C17H19N3O6

• Quantity: 50 mg
• Formula Weight: 361.37
• Purity: >99%
• Molecular Weight (g/mol): 361.354
• Chemical Name or Material: Varenicline tartrate

Safety and Handling

Recommended Storage

Desiccate at Room Temperature